Bharat Immunologicals and Biologicals Corporation Limited is an India-based biotechnology company. The Company is primarily engaged in the manufacture of oral polio vaccine, zinc tablet, and diarrhea management kit. It operates under various segment, namely oral polio vaccine, zinc tablets, BIB VIT, and BIBSANIT. It is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The Company is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). It is also diversified into plasma-derived medicines and Oral Cholera vaccines. The Company's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.As of 26 May 2026, BHARAT IMMUNOLOGICALS & BIOLOG share price is ₹17.39. The stock opened at ₹17.50, compared to its previous close of ₹17.53. During today's trading session, BHARAT IMMUNOLOGICALS & BIOLOG share price moved in the range of ₹17.10 to ₹17.80, with an average price of ₹17.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹17.10 and a high of ₹17.80.
The market capitalization of BHARAT IMMUNOLOGICALS & BIOLOG is ₹76 Crs, with a P/E ratio of -4.2 and a dividend yield of 0.00%.